Glucose Control In Hematopoetic Stem Cell Transplant
NCT: NCT00582036 · TERMINATED
NCT IDNCT00582036
StatusTERMINATED
Start Date2007-02
Completion2009-05
Brief Summary
To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)
Frequently Asked Questions
What is Glucose Control In Hematopoetic Stem Cell Transplant?
Glucose Control In Hematopoetic Stem Cell Transplant is a clinical trial registered under NCT00582036. Current status: TERMINATED.
What is the status of NCT00582036?
The current status of NCT00582036 (Glucose Control In Hematopoetic Stem Cell Transplant) is: TERMINATED.
When did Glucose Control In Hematopoetic Stem Cell Transplant start?
Glucose Control In Hematopoetic Stem Cell Transplant started on 2007-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.